IIT Guwahati launches cutting-edge BS programme in Biomedical Science and engineering in collaboration with AIIMS and NIPER

Syllad | The Rising MeghalayaApril 21, 2025

In a significant move to bridge the gap between engineering and healthcare, the Indian Institute of Technology (IIT) Guwahati has launched a new four-year Bachelor of Science (BS) programme in Biomedical Science and Engineering. The programme, offered by the Jyoti and Bhupat Mehta School of Health Sciences and Technology (JBMSHST), will be conducted in collaboration with two premier institutions—AIIMS Guwahati and NIPER Guwahati.

Designed to tackle the growing demand for interdisciplinary healthcare professionals, the programme integrates engineering, medical science, and pharmaceutical education. It aims to equip students with the skills and knowledge to work across sectors like medical technology, drug discovery, AI in healthcare, and bioinstrumentation.

Students will benefit from shared academic resources and faculty input from AIIMS and NIPER, ensuring exposure to both clinical and technological perspectives.

Real-world learning through interactions with medical professionals, hospital environments, and biomedical labs.

Courses include electrical systems, mechanics, pharmacology, bioinformatics, wearable tech, sensors, and AI-driven medical innovations.

In the final year, students can specialise in fields like neuroscience, personalised medicine, and pharma-engineering.

At the launch event, IIT Guwahati Director Prof. Devendra Jalihal said the programme reflects a forward-thinking approach to education. “The challenges of tomorrow demand solutions that go beyond traditional silos. This programme is a pioneering step towards preparing the next generation of innovators in healthcare and medical technology,” he said.

Prof. Ashok Puranik, Director of AIIMS Guwahati, praised the programme as a “landmark initiative” that combines genomics, AI, 3D printing, and nanotech with core biomedical engineering. “We’re creating an ecosystem for healthcare innovation,” he added.

Prof. U.S.N. Murty, Director of NIPER Guwahati, said the programme could evolve into a joint degree in the future, setting new standards in interdisciplinary medical education in India.

Rahul Mehta, Founder of the Mehta Family Foundation, which supports the initiative, called it a “thoughtful step forward” that merges the strengths of medicine and engineering. “Students passionate about math and biology will find this programme uniquely positioned to help them innovate in medical devices and drug development,” he said.

Students who passed or appeared for Class 12 with a minimum 75% aggregate marks in Physics, Chemistry, Mathematics, and Biology in 2024 or 2025 can apply for the programme. The programme is also open to IISER Aptitude Test 2025 qualifiers.

The programme offers promising career prospects in biomedical device manufacturing, AI-driven health tech, pharmacological research, and biotech innovation. With its real-world focus and collaborative model, it sets a new benchmark in undergraduate biomedical education in India.